Mealey's (September 27, 2019, 12:13 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Sept. 26 heard arguments on a plaintiffs’ motion to expand the scope of the valsartan NDMA multidistrict litigation to include losartan and irbesartan (In Re: Valsartan Products Liability Litigation, MDL Docket No. 2875, JPMDL)....